Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Varex Imaging NASDAQ: VREX reported fiscal second-quarter revenue within its guidance range and said demand remained solid across its medical and industrial businesses, while management highlighted a completed debt refinancing and continued investment in advanced imaging technologies.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Sunny S. Sanyal CEO | XSTU Exchange | US92214X1063 ISIN |
| US Country | 2,300 Employees | - Last Dividend | - Last Split | 20 Jan 2017 IPO Date |
Varex Imaging Corporation is a key player in the design and manufacture of X-ray imaging components, with operations that span across the globe including North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016 and headquartered in Salt Lake City, Utah, the company engages in two primary segments: Medical and Industrial. The Medical segment focuses on providing components for various radiographic applications, whereas the Industrial segment caters to security and inspection uses. Varex sells its products through a mix of channels, including original equipment manufacturers (OEMs), independent service companies, distributors, and direct sales to end-users.
The comprehensive range of Varex Imaging Corporation's products and services is distributed across two main segments: Medical and Industrial.